Showing results (1351-1360 of 6,719) with videos related to
Sort By:
Pageof 672
Annals of Hematology|June 30, 2025
Genotype-dependent albuminuria in adult sickle cell disease in KinshasaYannick Mompango Engole, Jean Robert Rissassi Makulo, Justine Busanga Bukabau, et al.Annals of Hematology|June 21, 2025
Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort studyXueqian Li, Hong Wang, Haohao Han, et al.Annals of Hematology|January 16, 2026
Lycorine inhibits the proliferation of acute myeloid leukemia cells by upregulating the expression of THBS1Lunbi Wu, Peng Liu, Bowen Jiang, et al.Annals of Hematology|January 13, 2026
A case report and a literature review of Myeloid/Lymphoid Neoplasm with Eosinophilia and PCM1::JAK2 rearrangement representing as B-cell acute lymphoblastic leukemia B-ALLLuka Čemažar, Klara Šlajpah, Njetočka Gredelj Šimec, et al.Annals of Hematology|December 10, 2025
Can platelet to neutrophil ratio (PNR) serve as a viable alternative tool for monitoring sickle cell disease patients on hydroxyurea in low income countries?Efobi Chilota Chibuife, Nri-Ezedi Chisom Adaobi, Franklin Odini, et al.Annals of Hematology|December 8, 2025
Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case reportMan Wu, Lin Huang, Yibin Yao, et al.Annals of Hematology|June 19, 2025
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndromeValeria Cardinali, Stefano Coiro, Maria Paola Martelli, et al.Annals of Hematology|February 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian expertsMattia D'Agostino, Marina Martello, Lorenzo De Paoli, et al.Annals of Hematology|December 18, 2024
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphomaJin-Feng Ma, Chun-Long Yan, Xu Jia, et al.Annals of Hematology|December 17, 2024
Prophylactic trimethoprim-sulfamethoxazole is safe in adult patients with primary central nervous system lymphoma receiving high-dose methotrexateQinxia Xu, Ziran Li, Tianling Ding, et al.Pageof 672